首页|木防己汤加减联合依托考昔治疗温热蕴结型急性痛风性关节炎的疗效及对患者炎性因子水平的影响

木防己汤加减联合依托考昔治疗温热蕴结型急性痛风性关节炎的疗效及对患者炎性因子水平的影响

扫码查看
目的 分析木防己汤加减联合依托考昔治疗温热蕴结型急性痛风性关节炎(AGA)患者的效果.方法 选取2021 年7 月—2022 年8月仁怀市人民医院收治的 90 例温热蕴结型AGA患者为研究对象,按随机数字表法将其分为对照组和观察组,各45 例.对照组采用依托考昔治疗,观察组在对照组基础上采用木防己汤加减治疗,两组均持续治疗2周.对比两组的临床疗效、中医证候评分、炎性因子水平及不良反应发生情况.结果 观察组治疗总有效率为97.78%,高于对照组的80.00%,差异有统计学意义(P﹤0.05).治疗后,观察组各项中医证候评分均低于对照组,组间差异有统计学意义(P﹤0.05);观察组白细胞介素-6、C反应蛋白、肿瘤坏死因子-α水平均低于对照组,组间差异有统计学意义(P﹤0.05).两组不良反应发生率对比,差异无统计学意义(P﹥0.05).结论 木防己汤加减联合依托考昔治疗温热蕴结型AGA患者有利于减轻关节疼痛,降低炎性因子水平,且安全可行.
Effect of Mufangji Decoction Combined with Etonocoxib on Dampness-Heat Accumulation Type of Acute Gouty Arthritis and the Level of Inflammatory Factors in Patients
Objective To analyze the effect of Mufangji decoction combined with etonocoxib on acute gouty arthritis(AGA)with dampness-heat accumulation type.Methods A total of 90 patients with AGA dampness-heat accumulation type admitted to Renhuai People's Hospital from July 2021 to August 2022 were selected as the research objects,and were divided into a control group and an observation group according to random number table method,with 45 cases in each group.The control group was treated with etonocoxib,and the observation group was treated with Mufangji decoction on the basis of the control group,both groups were treated for 2 weeks.The clinical efficacy,traditional chinese medicine syndrome score,inflammatory factor level and occurrence of adverse reactions were compared between the two groups.Results The total effective rate of the observation group was 97.78%,which was higher than 80.00%of the control group,the difference was statistically significant(P﹤0.05).After treatment,the scores of traditional chinese medicine syndrome in the observation group were lower than those in the control group,and the differences between the groups were statistically significant(P﹤0.05);the levels of interleukin-6,C-reactive protein and tumor necrosis factor-α in observation group were lower than those in control group,and the differences between the groups were statistically significant(P﹤0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P﹥0.05).Conclusion In the treatment of patients with AGA dampness-heat accumulation type,Mufangji decoction combined with etonocoxib can alleviate joint pain and reduce the level of inflammatory factors,and it is safe and feasible.

Acute gouty arthritisDampness-heat accumulation typeMufangji decoctionEtonocoxibAdverse reactions

杨艳芬

展开 >

仁怀市人民医院中医科,贵州仁怀 564500

急性痛风性关节炎 湿热蕴结型 木防己汤 依托考昔 不良反应

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(19)